Cervical Squamous Cell Carcinoma clinical trials

Explore recruiting cervical squamous cell carcinoma clinical trials.

Recruiting cervical squamous cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cervical Squamous Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1 Open-label Study to Evaluate the Safety and Efficacy of MK‑8294 Monotherapy in Advanced Solid Tumors

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)

Netherlands, France, Denmark, Germany, Norway, Italy +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Cervical Squamous Cell Carcinoma trials by city

Cervical Squamous Cell Carcinoma clinical trials

Recruiting cervical squamous cell carcinoma studies right now

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors

Dose Escalation Using Hypoxia-adjusted Radiotherapy

Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Also recruiting in Europe

A Phase 1 Open-label Study to Evaluate the Safety and Efficacy of MK‑8294 Monotherapy in Advanced Solid Tumors

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)

Cervical Squamous Cell Carcinoma trials by city

Other conditions